Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Arcus Biosciences Inc., 1 year.
Arcus Biosciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | Gilead Sciences Inc. | Option exercise | +533 | — | — |
| Jun 10, 2026 | Gilead Sciences Inc. | Shares withheld for tax | −263 | $121.48 | $31,949 |
| Mar 10, 2026 | Gilead Sciences Inc. | Option exercise | +2,133 | — | — |
| Mar 10, 2026 | Gilead Sciences Inc. | Shares withheld for tax | −1,063 | $148.56 | $157,919 |
| Feb 27, 2026 | Gilead Sciences Inc. | Grant or award | +8,530 | — | — |
| Jan 2, 2026 | Gilead Sciences Inc. | Option exercise | +16,326 | — | — |
| Jan 2, 2026 | Gilead Sciences Inc. | Shares withheld for tax | −6,944 | $121.60 | $844,390 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.